Skip to main content
Andrew Wang, MD

The American Institute for Medical and Biological Engineering (AIMBE) has inducted University of North Carolina Lineberger Comprehensive Cancer Center member Andrew Wang, MD, into its College of Fellows.

Wang, an associate professor in the UNC School of Medicine Department of Radiation Oncology and director of clinical and translational research in the department, and 156 other fellows were recognized at a formal ceremony during the AIMBE Annual Meeting at the National Academy of Sciences in Washington D.C., on Monday.

The fellowship honors those who have made outstanding contributions to “engineering and medicine research, practice, or education,” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering, or developing/implementing innovative approaches to bioengineering education.” Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer.

Wang was nominated, reviewed, and elected by peers and members of the college for “outstanding contributions in translating advances from nanomedicine and drug delivery research to improving cancer management and treatment.”

While most AIMBE Fellows are from the United States, the College of Fellows has inducted fellows representing 30 countries. AIMBE Fellows are employed in academia, industry, clinical practice and government. AIMBE Fellows are among the most distinguished medical and biological engineers including 2 Nobel Prize laureates, 17 recipients of the Presidential Medal of Science and/or Technology and Innovation, 158 inductees in the National Academy of Engineering, 72 inductees to the National Academy of Medicine and 31 inductees to the National Academy of Sciences.